Quantcast
Last updated on April 16, 2014 at 9:03 EDT

Latest Oncology Stories

2014-04-11 11:57:29

Most breast cancers are treated by blocking their addictions, for example depriving estrogen-fueled tumors of estrogen. But what about breast cancers without these hormonal addictions? In so-called "triple negative" tumors the cancer's addiction remains a mystery, making this subtype difficult to treat. However, a University of Colorado Cancer Center study presented today at the American Association for Cancer Research (AACR) Annual Meeting 2014 showcased a new drug active against...

2014-04-11 08:24:48

DUBLIN, Apr. 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/kp8jtp/breast_imaging ) has announced the addition of the "Breast Imaging Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Breast cancer is one of the most commonly diagnosed forms of cancer worldwide and is among the leading causes of cancer-related death in women....

2014-04-10 23:27:08

In CHAMPS Oncology's most recent blog post, Celebrating National Cancer Registrars Week, Toni Hare shares her thoughts on the topic. Cleveland, OH (PRWEB) April 10, 2014 In CHAMPS Oncology's most recent blog post, Celebrating National Cancer Registrars Week, Toni Hare shares her thoughts on the topic. Many people have known someone who has been affected by cancer in a way that made her first pursue a career in the cancer registry profession. Since then, her work has allowed her to...

2014-04-10 23:24:17

Mexican researchers say an alternative to the standard mesothelioma chemotherapy regimen can not only improve survival and quality of life, but can also save money. Raleigh, NC (PRWEB) April 10, 2014 Scientists in the Thoracic Oncology Unit at Mexico’s National Cancer Institute say continuous infusions of low-dose Gemzar (gemcitabine) with cisplatin appear to be a safe and effective alternative to standard mesothelioma chemotherapy. Click here to read about the new study on the...

2014-04-10 12:24:44

Emerging Therapies are Not Expected to Offer Improvements in Safety and Tolerability Attributes, According to Findings from Decision Resources Group BURLINGTON, Mass., April 10, 2014 /PRNewswire/ -- Decision Resources Group finds that the effect of a therapy on overall survival and progression-free survival are attributes that most influence surveyed U.S. and European hematological oncologists' prescribing decisions for relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic...

2014-04-10 08:30:44

SuperSibs! becomes part of Alex's Lemonade Stand Foundation, program continues providing comfort and care services to siblings of children with cancer PHILADELPHIA, April 10, 2014 /PRNewswire-USNewswire/ -- Alex's Lemonade Stand Foundation (ALSF), a nonprofit dedicated to finding cures for all kids with cancer is honored to announce the acquisition of SuperSibs!, an organization that has worked to ensure support for siblings of children with cancer. With a keen understanding of the...

2014-04-10 08:30:03

Professor Riccardo Lencioni is giving an honorary lecture on April 24, 2014 which will highlight the latest findings and lessons learned from the HEAT Study and the design of the Phase III OPTIMA Study LAWRENCEVILLE, N.J., April 10, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today that Professor Riccardo Lencioni, MD, FSIR, EBIR, Professor and Director of the Diagnostic Imaging and Intervention at the Pisa University School of Medicine in Italy, former ECIO President,...

2014-04-10 08:28:33

DUBLIN, April 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/qxfqmk/drug_delivery_in) has announced the addition of a new report "Drug Delivery in Cancer - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/qxfqmk/drug_delivery_in ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Drug delivery remains a challenge in management of cancer. Approximately 12.5...

2014-04-09 23:25:06

Biochemical testing suggests a pair of proteins can find and monitor bladder cancer better than standard techniques. Raleigh, NC (PRWEB) April 09, 2014 A team of Egyptian biochemists say angiogenin and clusterin – two proteins vital to certain cellular processes – could make bladder cancer diagnosis more accurate and treatments more effective. Click here to read details on the study which has just been posted on the Cancer Monthly website. Researchers with the Faculty of...

2014-04-09 16:37:59

The findings shed more light on cancer development and metastasis. The push and pull of physical force can cause profound changes in the behavior of a cell. Two studies from researchers working at the UNC Lineberger Comprehensive Cancer Center reveal how cells respond to mechanical manipulation, a key factor in addressing the underlying causes of cancer and other diseases. The studies, published in Nature Cell Biology and the Journal of Immunology, have their roots in a longtime...